KMPH Insider Trading

Insider Ownership Percentage: 1.10%
Insider Buying (Last 12 Months): $105,626.10
Insider Selling (Last 12 Months): $0.00

KemPharm Insider Trading History Chart

This chart shows the insider buying and selling history at KemPharm by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

KemPharm Share Price & Price History

Current Price: $5.71
Price Change: Price Decrease of -0.12 (-2.06%)
As of 09/26/2022 02:30 PM ET

This chart shows the closing price history over time for KMPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

KemPharm Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2022David S. TierneyDirectorBuy2,000$4.39$8,780.005,835View SEC Filing Icon  
5/25/2022Travis C. MickleCEOBuy3,000$4.37$13,110.0039,521View SEC Filing Icon  
5/20/2022Tamara A SeymourDirectorBuy200$4.87$974.00200View SEC Filing Icon  
5/18/2022R. LaDuane CliftonCFOBuy1,200$5.00$6,000.006,440View SEC Filing Icon  
5/18/2022Richard W. PascoeChairmanBuy5,000$4.92$24,600.008,285View SEC Filing Icon  
11/30/2021David S. TierneyDirectorBuy2,000$7.79$15,580.00View SEC Filing Icon  
11/30/2021Richard W. PascoeChairmanBuy1,500$7.88$11,820.00View SEC Filing Icon  
11/18/2021R. LaDuane CliftonCFOBuy510$8.29$4,227.90View SEC Filing Icon  
11/18/2021Travis C. MickleCEOBuy2,250$8.23$18,517.50View SEC Filing Icon  
9/29/2021R. LaDuane CliftonCFOBuy215$9.38$2,016.70View SEC Filing Icon  
9/20/2021R. LaDuane CliftonCFOBuy935$8.59$8,031.654,515View SEC Filing Icon  
9/1/2021R. LaDuane CliftonCFOBuy230$9.11$2,095.303,580View SEC Filing Icon  
8/30/2021Travis C. MickleCEOBuy5,000$8.92$44,600.0034,271View SEC Filing Icon  
6/23/2021R. LaDuane CliftonCFOBuy75$14.11$1,058.253,350View SEC Filing Icon  
5/27/2021R. LaDuane CliftonCFOBuy150$9.85$1,477.503,275View SEC Filing Icon  
5/13/2021Samuel J. BraunMajor ShareholderBuy10,000$8.55$85,500.00View SEC Filing Icon  
8/26/2020R. LaDuane CliftonCFOBuy1,000$0.84$840.00
8/18/2020R. LaDuane CliftonCFOBuy2,000$0.70$1,400.00
8/18/2020Richard W. PascoeDirectorBuy10,000$0.64$6,400.00
6/11/2020R. LaDuane CliftonCFOBuy1,500$0.19$285.00
6/2/2020Travis C. MickleCEOBuy110,000$0.18$19,800.00
5/26/2020R. LaDuane CliftonCFOBuy11,500$0.19$2,185.00
3/25/2020R. LaDuane CliftonCFOBuy1,000$0.22$220.0034,000View SEC Filing Icon  
3/13/2020Timothy J SangiovanniVPBuy4,000$0.20$800.0018,000View SEC Filing Icon  
3/11/2020R. LaDuane CliftonCFOBuy8,000$0.25$2,000.0033,000View SEC Filing Icon  
3/9/2020Timothy J SangiovanniVPBuy333$0.25$83.256,333View SEC Filing Icon  
3/5/2020Travis C. MickleCEOBuy25,000$0.31$7,750.00
12/31/2019Gordon K JohnsonInsiderBuy20,000$0.41$8,200.00
12/27/2019R. LaDuane CliftonCFOBuy12,250$0.42$5,145.0017,750View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for KemPharm (NASDAQ:KMPH)

20.85% of KemPharm stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KMPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

KemPharm Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/18/2022Goldman Sachs Group Inc.77,140$0.34M0.0%-49.3%0.224%Search for SEC Filing on Google Icon
8/16/2022Kingsview Wealth Management LLC12,120$54K0.0%N/A0.035%Search for SEC Filing on Google Icon
8/15/2022Occudo Quantitative Strategies LP42,348$0.19M0.0%-28.2%0.123%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC107,341$0.48M0.0%-48.9%0.312%Search for SEC Filing on Google Icon
8/15/2022State Street Corp102,640$0.46M0.0%-81.4%0.298%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC29,939$0.13M0.0%N/A0.087%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP582,261$2.60M0.0%N/A1.691%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC337,247$1.50M0.0%+5.3%0.980%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC13,042$58K0.0%-65.0%0.038%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC103,394$0.46M0.0%-42.8%0.300%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp52,791$0.24M0.0%-79.4%0.153%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG5,798$26K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.32,004$0.14M0.0%N/A0.093%Search for SEC Filing on Google Icon
8/3/2022Janney Montgomery Scott LLC479,220$2.17M0.0%+36.9%1.392%Search for SEC Filing on Google Icon
7/8/2022HealthInvest Partners AB670,000$2.99M6.9%+162.7%1.947%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE145,074$0.73M0.0%+340.8%0.421%Search for SEC Filing on Google Icon
5/17/2022Virtu Financial LLC37,219$0.19M0.0%N/A0.108%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC26,878$0.14M0.0%-66.4%0.078%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada10,879$55K0.0%-28.0%0.032%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System12,819$64K0.0%-23.0%0.037%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.152,158$0.77M0.0%-20.2%0.442%Search for SEC Filing on Google Icon
5/16/2022State Street Corp551,615$2.78M0.0%+2.4%1.602%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP22,700$0.11M0.0%N/A0.066%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.10,208$51K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC180,791$0.91M0.0%+877.2%0.525%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp256,608$1.29M0.0%-3.7%0.745%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,516,912$7.63M0.0%+2.2%4.407%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.2,253,334$11.33M0.0%+0.8%6.546%Search for SEC Filing on Google Icon
5/12/2022Martingale Asset Management L P75,612$0.38M0.0%+19.6%0.220%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp163,617$0.82M0.0%+87.3%0.475%Search for SEC Filing on Google Icon
5/11/2022Mystic Asset Management Inc.104,081$0.52M0.3%+44.6%0.302%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.18,095$91K0.0%+28.3%0.053%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP83,952$0.42M0.1%N/A0.244%Search for SEC Filing on Google Icon
5/6/2022Retirement Planning Co of New England Inc.243,891$1.23M0.7%+15.6%0.709%Search for SEC Filing on Google Icon
5/6/2022Arete Wealth Advisors LLC75,932$0.38M0.0%+24.6%0.221%Search for SEC Filing on Google Icon
5/5/2022HealthInvest Partners AB255,000$1.28M2.0%N/A0.741%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.13,300$66K0.0%N/A0.039%Search for SEC Filing on Google Icon
4/20/2022Strategic Asset Management LLC40,087$0.20M0.3%+16.7%0.116%Search for SEC Filing on Google Icon
3/11/2022City State Bank13,724$71K0.0%N/A0.039%Search for SEC Filing on Google Icon
2/23/2022Mystic Asset Management Inc.71,981$0.63M0.3%N/A0.206%Search for SEC Filing on Google Icon
2/16/2022SG3 Management LLC37,500$0.33M0.0%-65.1%0.107%Search for SEC Filing on Google Icon
2/8/2022Retirement Planning Co of New England Inc.211,068$1.84M0.9%N/A0.603%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC11,452$100K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp266,544$2.32M0.0%+1.4%0.755%Search for SEC Filing on Google Icon
2/7/2022Arete Wealth Advisors LLC60,954$0.56M0.0%+7.8%0.173%Search for SEC Filing on Google Icon
2/3/2022Nisa Investment Advisors LLC3,650$26K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/27/2022Janney Montgomery Scott LLC285,915$2.49M0.0%+2.3%0.810%Search for SEC Filing on Google Icon
1/25/2022Belvedere Trading LLC33,888$0.22M0.0%+88.3%0.096%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio42,500$0.37M0.0%+543.9%0.120%Search for SEC Filing on Google Icon
1/18/2022Kovack Advisors Inc.88,297$0.77M0.1%+29.4%0.250%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY3,598$34K0.0%-59.5%0.010%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP109,936$1.03M0.0%+540.9%0.313%Search for SEC Filing on Google Icon
11/15/2021Martingale Asset Management L P62,887$0.59M0.0%+207.9%0.179%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC165,600$1.55M0.0%N/A0.471%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company14,642$0.14M0.0%-11.5%0.042%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC488,732$4.56M0.0%+3.4%1.390%Search for SEC Filing on Google Icon
11/12/2021Blueshift Asset Management LLC14,702$0.14M0.0%+11.8%0.042%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.168,689$1.57M0.0%N/A0.480%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.3,257$30K0.0%+139.5%0.009%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.11,400$0.11M0.0%-50.0%0.032%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,959,438$18.28M0.0%-0.5%5.575%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.4,535$42K0.0%+357.2%0.013%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG16,434$0.15M0.0%-13.4%0.047%Search for SEC Filing on Google Icon
11/4/2021Strategic Asset Management LLC34,365$0.30M0.4%N/A0.098%Search for SEC Filing on Google Icon
11/3/2021Kovack Advisors Inc.68,260$0.64M0.1%+13.1%0.194%Search for SEC Filing on Google Icon
11/2/2021Heritage Wealth Advisors8,000$75K0.0%N/A0.023%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund13,402$0.13M0.0%-45.3%0.038%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC13,689$0.13M0.0%N/A0.039%Search for SEC Filing on Google Icon
10/29/2021Janney Montgomery Scott LLC279,440$2.61M0.0%+8.0%0.795%Search for SEC Filing on Google Icon
10/19/2021Belvedere Trading LLC17,996$0.17M0.0%-36.9%0.051%Search for SEC Filing on Google Icon
10/19/2021Stratos Wealth Partners LTD.70,957$0.66M0.0%N/A0.202%Search for SEC Filing on Google Icon
10/14/2021Private Advisor Group LLC10,790$0.10M0.0%N/A0.031%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC71,435$0.92M0.1%+87.0%0.203%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP17,153$0.22M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY8,881$0.11M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/17/2021MetLife Investment Management LLC11,600$0.15M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC441,416$5.66M0.2%N/A1.302%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC11,403$0.15M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System39,418$0.51M0.0%N/A0.116%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP10,500$0.14M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.71,732$0.92M0.0%N/A0.212%Search for SEC Filing on Google Icon
8/16/2021State Street Corp493,808$6.33M0.0%N/A1.457%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC110,717$1.42M0.0%N/A0.327%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP17,153$0.22M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp277,756$3.56M0.0%+630.2%0.819%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC13,250$0.17M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/13/2021Blueshift Asset Management LLC13,153$0.17M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC472,854$6.06M0.0%+165.7%1.395%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,209,047$15.50M0.0%+47.8%3.567%Search for SEC Filing on Google Icon
8/12/2021Legal & General Group Plc2,642$34K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/12/2021The Manufacturers Life Insurance Company16,550$0.21M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp72,645$0.93M0.0%N/A0.214%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,968,378$25.24M0.0%+3,242.9%5.807%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG18,987$0.24M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC26,892$0.35M0.0%-8.7%0.079%Search for SEC Filing on Google Icon
8/11/2021CVI Holdings LLC244,274$3.13M0.2%N/A0.721%Search for SEC Filing on Google Icon
8/9/2021Arete Wealth Advisors LLC56,401$0.72M0.1%+6.7%0.166%Search for SEC Filing on Google Icon
8/6/2021Ameritas Investment Partners Inc.2,241$29K0.0%N/A0.007%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers31,832$0.41M0.0%N/A0.094%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund24,500$0.31M0.0%N/A0.072%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
KemPharm logo
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. Its prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, stimulant use disorder, and CNS rare diseases, including idiopathic hypersomnia (IH). The company's lead product candidate KP1077 which is under Phase II clinical trial for the treatment of IH and narcolepsy, is based on its prodrug of d-methylphenidate, known as serdexmethylphnidate. It is also developing KP879, a prodrug product candidate for the treatment of stimulant use disorder and is under Phase I clinical trial. In addition, the company has received FDA approval for AZSTARYS, a new once-daily treatment for attention deficit hyperactivity disorder in patents age six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen. KemPharm, Inc. has collaboration and license agreement, with KVK-Tech, Inc. and Commave Therapeutics SA. The company was incorporated in 2006 and is headquartered in Celebration, Florida.
Read More on KemPharm

Today's Range

Now: $5.71
Low: $5.67
High: $5.95

50 Day Range

MA: $5.80
Low: $5.29
High: $6.85

52 Week Range

Now: $5.71
Low: $4.00
High: $10.80

Volume

3,099 shs

Average Volume

419,383 shs

Market Capitalization

$196.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.78

Who are the company insiders with the largest holdings of KemPharm?

KemPharm's top insider investors include:
  1. Travis C Mickle (CEO)
  2. Richard W Pascoe (Chairman)
  3. R Laduane Clifton (CFO)
  4. David S Tierney (Director)
  5. Tamara A Seymour (Director)
  6. Samuel J Braun (Major Shareholder)
Learn More about top insider investors at KemPharm.

Who are the major institutional investors of KemPharm?

KemPharm's top institutional investors include:
  1. HealthInvest Partners AB — 1.95%
  2. Laurion Capital Management LP — 1.69%
  3. Janney Montgomery Scott LLC — 1.39%
  4. Millennium Management LLC — 0.98%
  5. AQR Capital Management LLC — 0.31%
  6. Renaissance Technologies LLC — 0.30%
Learn More about top institutional investors of KemPharm stock.

Which major investors are selling KemPharm stock?

During the previous quarter, KMPH stock was sold by these institutional investors:
  1. State Street Corp
  2. Group One Trading L.P.
  3. Northern Trust Corp
  4. AQR Capital Management LLC
  5. Renaissance Technologies LLC
  6. Goldman Sachs Group Inc.
  7. Virtu Financial LLC
  8. Occudo Quantitative Strategies LP

Which major investors are buying KemPharm stock?

In the previous quarter, KMPH stock was bought by institutional investors including:
  1. Laurion Capital Management LP
  2. HealthInvest Partners AB
  3. Janney Montgomery Scott LLC
  4. Principal Financial Group Inc.
  5. Cubist Systematic Strategies LLC
  6. Millennium Management LLC
  7. Kingsview Wealth Management LLC
  8. UBS Group AG
During the previous year, these company insiders have bought KemPharm stock:
  1. Travis C Mickle (CEO)
  2. Richard W Pascoe (Chairman)
  3. R Laduane Clifton (CFO)
  4. David S Tierney (Director)
  5. Tamara A Seymour (Director)
  6. Samuel J Braun (Major Shareholder)
Learn More investors buying KemPharm stock.